A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443–459. doi:10.3322/caac.21637
   PubMed Web of Science ®Google Scholar
• Pei Y, Chen X, Zhang W. Liver resection for BCLC 0-A stage hepatocellular carcinoma: does the time to surgery not impact the prognosis? J Hepatol. 2018;68(5):1101. doi:10.1016/j.jhep.2017.12.032
   PubMed Web of Science ®Google Scholar
• Li C, Wen TF. Does surgical resection provide better outcomes than radiofrequency ablation in patients with BCLC very early-stage hepatocellular carcinoma? Ann Surg. 2017;266(6):e54–e55. doi:10.1097/SLA.0000000000001357
   PubMed Web of Science ®Google Scholar
• Liang L, Xing H, Zhang H, et al. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis. HPB. 2018;20(2):110–119. doi:10.1016/j.hpb.2017.10.004
   PubMed Web of Science ®Google Scholar
• Ren ZG, Lin ZY, Xia JL, et al. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol. 2004;10(19):2791–2794. doi:10.3748/wjg.v10.i19.2791
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang B, Yin X, Ren Z, Qiu S, Zhou J. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol. 2013;139(5):773–781.
   PubMed Web of Science ®Google Scholar
• Kluger MD, Halazun KJ, Barroso RT, et al. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl. 2014;20(5):536–543. doi:10.1002/lt.23846
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Dou C, et al. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics. 2018;8(17):4649–4663. doi:10.7150/thno.26789
   PubMed Web of Science ®Google Scholar
• Dou C, Zhou Z, Xu Q, et al. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway. Oncogene. 2019;38(8):1239–1255. doi:10.1038/s41388-018-0505-8
   PubMed Web of Science ®Google Scholar
• Guo BJ, Ruan Y, Wang YJ, et al. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/beta-catenin pathway under hypoxia. J Integr Med. 2023;21(5):474–486. doi:10.1016/j.joim.2023.06.008
   PubMedGoogle Scholar
• Rhee H, Nahm JH, Kim H, et al. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Mod Pathol. 2016;29(9):1038–1049. doi:10.1038/modpathol.2016.111
   PubMed Web of Science ®Google Scholar
• Ambros V, Bartel B, Bartel DP, et al. A uniform system for microRNA annotation. Rna. 2003;9(3):277–279. doi:10.1261/rna.2183803
   PubMed Web of Science ®Google Scholar
• Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res. Int. 2015;2015:125094. doi:10.1155/2015/125094
   PubMed Web of Science ®Google Scholar
• Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genet. 2006;38(2):228–233. doi:10.1038/ng1725
   PubMed Web of Science ®Google Scholar
• Suksangrat T, Phannasil P, Jitrapakdee S. miRNA regulation of glucose and lipid metabolism in relation to diabetes and non-alcoholic fatty liver disease. Adv Exp Med Biol. 2019;1134:129–148.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li XY, Li ZY, Li M, Liu ZD. Moxibustion regulates T-regulatory/T-helper 17 cell balance by modulating the microRNA-221/suppressor of cytokine signaling 3 axis in a mouse model of rheumatoid arthritis. J Integr Med. 2022;20(5):453–462. doi:10.1016/j.joim.2022.06.002
   PubMedGoogle Scholar
• Ali HEA, Emam AA, Zeeneldin AA, et al. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization. Clin Biochem. 2019;65:45–52. doi:10.1016/j.clinbiochem.2019.01.002
   PubMed Web of Science ®Google Scholar
• Pinjaroen N, Chailapakul P, Sriphoosanaphan S, Chuaypen N, Tangkijvanich P. Predictive role of pretreatment circulating miR-221 in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Diagnostics. 2023;13(17):2794. doi:10.3390/diagnostics13172794
   Web of Science ®Google Scholar
• Pelizzaro F, Cardin R, Sartori A, et al. Circulating MicroRNA-21 and MicroRNA-122 as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization. Biomedicines. 2021;9(8):890. doi:10.3390/biomedicines9080890
   PubMed Web of Science ®Google Scholar
• Liu T, Tang J, Li X, et al. The key network of mRNAs and miRNAs regulated by HIF1A in hypoxic hepatocellular carcinoma cells. Front Genet. 2022;13:857507. doi:10.3389/fgene.2022.857507
   PubMed Web of Science ®Google Scholar
• Zhao B, Ke K, Wang Y, et al. HIF-1alpha and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis. Signal Transduct Target Ther. 2020;5(1):118. doi:10.1038/s41392-020-00223-6
   PubMed Web of Science ®Google Scholar
• Jia W, Liang S, Lin W, et al. Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway. Int J Biol Sci. 2023;19(15):4744–4762. doi:10.7150/ijbs.86767
   PubMed Web of Science ®Google Scholar
• Yao M, Liang S, Cheng B. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. Front Pharmacol. 2023;14:1110922. doi:10.3389/fphar.2023.1110922
   PubMed Web of Science ®Google Scholar
• Wei X, Zhao L, Ren R, et al. MiR-125b loss activated HIF1alpha/pAKT Loop, leading to transarterial chemoembolization resistance in hepatocellular carcinoma. Hepatology. 2021;73(4):1381–1398. doi:10.1002/hep.31448
   PubMed Web of Science ®Google Scholar
• Du C, Weng X, Hu W, et al. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34(1):67. doi:10.1186/s13046-015-0182-1
   PubMedGoogle Scholar
• Wei R, Huang GL, Zhang MY, et al. Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma. Clin Cancer Res. 2013;19(17):4780–4791. doi:10.1158/1078-0432.CCR-12-2728
   PubMed Web of Science ®Google Scholar
• Xie QY, Almudevar A, Whitney-Miller CL, Barry CT, McCall MN. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity. BMC Med Genomics. 2016;9(1):18. doi:10.1186/s12920-016-0179-4
   PubMedGoogle Scholar
• Barry CT, D’Souza M, McCall M, et al. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant. 2012;12(2):428–437. doi:10.1111/j.1600-6143.2011.03788.x
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B. 1995;57(1):289–300.
   Google Scholar
• Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics. 2004;20(1):93–99. doi:10.1093/bioinformatics/btg382
   PubMed Web of Science ®Google Scholar
• Liu Z, Guo C, Dang Q, et al. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer. EBioMedicine. 2022;75:103750. doi:10.1016/j.ebiom.2021.103750
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. doi:10.1038/s41467-022-28421-6
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Suthen S, Lim CJ, Nguyen PHD, et al. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC. Hepatology. 2022;76(5):1329–1344. doi:10.1002/hep.32419
   PubMed Web of Science ®Google Scholar
• Sceneay J, Parker BS, Smyth MJ, Moller A. Hypoxia-driven immunosuppression contributes to the pre-metastatic niche. Oncoimmunology. 2013;2(1):e22355. doi:10.4161/onci.22355
   PubMed Web of Science ®Google Scholar
• Huang DH, Wang GY, Zhang JW, Li Y, Zeng XC, Jiang N. MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma. Jpn J Clin Oncol. 2015;45(8):738–744. doi:10.1093/jjco/hyv063
   PubMed Web of Science ®Google Scholar
• Fan D, Ren B, Yang X, Liu J, Zhang Z. Upregulation of miR-501-5p activates the wnt/beta-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer. J Exp Clin Cancer Res. 2016;35(1):177. doi:10.1186/s13046-016-0432-x
   PubMedGoogle Scholar
• Ma X, Feng J, Lu M, et al. microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1. J Cell Biochem. 2020;121(2):1911–1922. doi:10.1002/jcb.29426
   PubMed Web of Science ®Google Scholar
• Ren Y, Chen Y, Liang X, Lu Y, Pan W, Yang M. MiRNA-638 promotes autophagy and malignant phenotypes of cancer cells via directly suppressing DACT3. Cancer Lett. 2017;390:126–136. doi:10.1016/j.canlet.2017.01.009
   PubMed Web of Science ®Google Scholar
• Teng L, Li Z, Shi Y, et al. Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family. Transl Oncol. 2022;26:101547. doi:10.1016/j.tranon.2022.101547
   PubMed Web of Science ®Google Scholar
• Strommer J. The plant ADH gene family. Plant J. 2011;66(1):128–142. doi:10.1111/j.1365-313X.2010.04458.x
   PubMed Web of Science ®Google Scholar
• Wei R, Li P, He F, et al. Comprehensive analysis reveals distinct mutational signature and its mechanistic insights of alcohol consumption in human cancers. Brief Bioinform. 2021;22(3). doi:10.1093/bib/bbaa066
   Web of Science ®Google Scholar
• Liu J, Yang HI, Lee MH, et al. Alcohol drinking mediates the association between polymorphisms of ADH1B and ALDH2 and Hepatitis B-related hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25(4):693–699. doi:10.1158/1055-9965.EPI-15-0961
   PubMed Web of Science ®Google Scholar
• Liu X, Li T, Kong D, You H, Kong F, Tang R. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma. BMC Cancer. 2020;20(1):1204. doi:10.1186/s12885-020-07689-1
   PubMed Web of Science ®Google Scholar
• Lin Z, Huang W, He Q, et al. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter. J Exp Clin Cancer Res. 2021;40(1):50. doi:10.1186/s13046-021-01829-6
   PubMed Web of Science ®Google Scholar
• Zhang H, Song Y, Zhou C, et al. Blocking Endogenous H(2)S signaling attenuated radiation-induced long-term metastasis of residual HepG2 Cells through inhibition of EMT. Radiat Res. 2018;190(4):374–384. doi:10.1667/RR15074.1
   PubMed Web of Science ®Google Scholar
• Terry S, Buart S, Chouaib S. Hypoxic Stress-induced tumor and immune plasticity, suppression, and impact on tumor heterogeneity. Front Immunol. 2017;8:1625. doi:10.3389/fimmu.2017.01625
   PubMed Web of Science ®Google Scholar
• Guo W, Qiao T, Dong B, Li T, Liu Q, Xu X. The effect of hypoxia-induced exosomes on anti-tumor immunity and its implication for immunotherapy. Front Immunol. 2022;13:915985. doi:10.3389/fimmu.2022.915985
   PubMed Web of Science ®Google Scholar
• Genova C, Dellepiane C, Carrega P, et al. Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade. Front Immunol. 2021;12:799455. doi:10.3389/fimmu.2021.799455
   PubMed Web of Science ®Google Scholar
• He Y, Luo J, Zhang G, et al. Single-cell profiling of human CD127(+) innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. Hepatology. 2022;76(4):1013–1029. doi:10.1002/hep.32444
   PubMed Web of Science ®Google Scholar
• You Y, Wen D, Zeng L, et al. ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression. Int J Biol Sci. 2022;18(13):5001–5018. doi:10.7150/ijbs.70149
   PubMed Web of Science ®Google Scholar
• Chen J, Ji K, Gu L, Fang Y, Pan M, Tian S. HMGA1 promotes macrophage recruitment via activation of NF-κB-CCL2 signaling in hepatocellular carcinoma. J Immunol Res. 2022;2022:4727198. doi:10.1155/2022/4727198
   PubMed Web of Science ®Google Scholar
• Laoui D, Keirsse J, Morias Y, et al. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nat Commun. 2016;7(1):13720. doi:10.1038/ncomms13720
   PubMed Web of Science ®Google Scholar
• Scarlett UK, Rutkowski MR, Rauwerdink AM, et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med. 2012;209(3):495–506. doi:10.1084/jem.20111413
   PubMed Web of Science ®Google Scholar